PubMed 5. Zheng X, Jiang F, Katakowski M, Zhang X, Jiang H, Zhang ZG, Chopp M: Sensitization of cerebral tissue
in Alisertib clinical trial nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion. Cancer Lett 2008, 265: 177–187.CrossRefPubMed 6. Zheng X, Jiang F, Katakowski M, Kalkanis SN, Hong X, Zhang X, Zhang ZG, Yang H, Chopp M: Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness. Cancer Sci 2007, 98: 674–684.CrossRefPubMed 7. Takamune Y, Ikebe T, Nagano O, Shinohara M: Involvement of NF-kappaB-mediated maturation of ADAM-17 in the invasion of oral squamous cell carcinoma. Biochem Biophys Res Commun 2008, 365: 393–398.CrossRefPubMed 8. Arribas J, Esselens C: ADAM17 as a Therapeutic Target in Multiple SB273005 manufacturer BKM120 price Diseases. Curr Pharm Des 2009, 15: 2319–2335.CrossRefPubMed 9. Glunde K, Stasinopoulos I: ADAM17: the new face of breast cancer-promoting metalloprotease activity. Cancer Biol Ther 2009, 8: 1151–1153. 10. Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J: TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J 2003, 22: 1114–1124.CrossRefPubMed 11. Canning M, Postovit L, Clarke S, Graham C:
Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells. Exp Cell Res 2001, 267: 88–94.CrossRefPubMed 12. Hocker M, Raychowdhury R, Plath T, Wu H, O’Connor DT, Wiedenmann B, Rosewicz S, Wang TC: Sp1 and CREB mediate gastrin-dependent regulation of chromogranin A promoter activity in gastric carcinoma cells. J Biol Chem 1998, 273: 34000–34007.CrossRefPubMed
13. Lin L, Shihua H, Jian-Min S, James R: Gene Regulation by Sp1 and Sp3. Biochem Cell Biol 2004, 82: 460–471.CrossRef 14. Wang L, Guan X, Zhang J, Jia Z, Wei D, Li Q, Yao J, Xie K: Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models. Int J Oncol 2008, 33: 161–167.PubMed 15. Wang LW, Li Q, Hua ZL, Zhou F, Keping X, Daoyan W, Yao J, Ajani J: [Expression of transcription Montelukast Sodium factor Sp1 in human gastric cancer tissue and its correlation with prognosis]. Zhonghua Zhong Liu Za Zhi 2007, 29: 107–111.PubMed 16. Yoshiharu M, Kazuto Y, Koji S, Isao T: cDNA cloning of mouse tumor necrosis factor-alpha converting enzyme (TACE) and partial analysis of its promoter. Gene 1999, 233: 67–74.CrossRef 17. Iyer NV, Leung SW, Semenza GL: The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation. Genomics 1998, 52: 159–165.CrossRefPubMed 18. Asai M, Hattori C, Szabo B, Sasagawa N, Maruyama K, Tanuma S, Ishiura S: Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem Biophys Res Commun 2003, 301: 231–235.CrossRefPubMed 19. Tai T, Wong-Faull D, Claycomb R, Wong D: Hypoxic stress-induced changes in adregenic function: role of HIF-1alpha. Journal of Neurochemistry 2009, 109: 513–524.CrossRefPubMed 20.